💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for GlycoMimetics, Inc. (GLYC)
« Back to company indexGLYC Chatter Timeline
Stock Ticker for GLYC
Most Active Tweeters for GLYC
| User | Tweets |
|---|---|
| @FlashAlert_me | 5 |
| @InsiderAlerts4U | 5 |
| @Tickeron | 4 |
| @BlueBioNow | 3 |
| @newsfilterio | 3 |
Recent Tweets for GLYC
 |
@Tickeron $GLYC in Uptrend: 50-day Moving Average moved above 200-day Moving Average on November 17, 2020. View odds for this… https://t.co/9lliMbZlHY 2:01am |
 |
@InsiderAlerts4U $GLYC: New Insider Filing on GLYCOMIMETICS INC's SVP of Research, CSO JOHN L. MAGNANI: https://t.co/9IkJsXhHFo January 23rd 2021, 5:01am |
 |
@newsfilterio 96,250 shares acquired by King Rachel K. (President, CEO), reported in a new form 4 filed with the SEC $GLYC https://t.co/wY17ccRRYi January 23rd 2021, 4:01am |
|
@newsfilterio 34,500 shares acquired by Magnani John L. (SVP of Research, CSO), reported in a new form 4 filed with the SEC $GLYC https://t.co/TrB753M6fd January 23rd 2021, 4:01am |
|
@newsfilterio 34,500 shares acquired by Hahn Brian M. (SVP Finance, CFO), reported in a new form 4 filed with the SEC $GLYC https://t.co/O8KTYoBWO0 January 23rd 2021, 3:01am |
|
@InsiderAlerts4U $GLYC: New Insider Filing on GLYCOMIMETICS INC's SVP, Chief Business Officer ARMAND GIRARD: https://t.co/VqqwWWnqRt January 22nd 2021, 11:01pm |
|
@InsiderAlerts4U $GLYC: New Insider Filing on GLYCOMIMETICS INC's SVP Clinical Development, CMO HELEN M. THACKRAY: https://t.co/IKwNUo3qMH January 22nd 2021, 9:01pm |
|
@InsiderAlerts4U $GLYC: New Insider Filing on GLYCOMIMETICS INC's SVP Finance, CFO BRIAN M. HAHN: https://t.co/bA0WJsxaaM January 22nd 2021, 9:01pm |
|
@InsiderAlerts4U $GLYC: New Insider Filing on GLYCOMIMETICS INC's President, CEO RACHEL K. KING: https://t.co/mBlRNzleGb January 22nd 2021, 9:01pm |
 |
@FlashAlert_me $GLYC [15s. delayed] filed SEC form 4: SVP, Chief Business Officer Girard Armand: Granted 25,000 of Common Stock a… https://t.co/1Ti2Bxyqoh January 22nd 2021, 9:01pm |
|
@FlashAlert_me $GLYC [15s. delayed] filed SEC form 4: SVP Finance, CFO Hahn Brian M.: Granted 34,500 of Common Stock at price $0… https://t.co/tgHKFnXEej January 22nd 2021, 9:01pm |
|
@FlashAlert_me $GLYC [15s. delayed] filed SEC form 4: SVP Clinical Development, CMO Thackray Helen M.: Granted 34,500 of Common S… https://t.co/VEcawjOKm5 January 22nd 2021, 9:01pm |
|
@FlashAlert_me $GLYC [15s. delayed] filed SEC form 4: SVP of Research, CSO Magnani John L.: Granted 34,500 of Common Stock at pri… https://t.co/yJPSEN1HEs January 22nd 2021, 9:01pm |
|
@FlashAlert_me $GLYC [15s. delayed] filed SEC form 4: President, CEO King Rachel K.: Granted 96,250 of Common Stock at price $0 o… https://t.co/4IXzCHvcvq January 22nd 2021, 9:01pm |
|
@Tickeron $GLYC's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/Z8OU90ZShl January 21st 2021, 7:01am |
 |
@BlueBioNow $GLYC price movement 2.39 % https://t.co/XgwQoI5WeD January 20th 2021, 2:01am |
|
@Tickeron $GLYC in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on November 17, 2020. View odds for th… https://t.co/SzIco4UFO7 January 19th 2021, 8:01pm |
 |
@ChartMill $GLYC was analyzed by 5 analysts. The buy consensus is at 92%. So analysts seem to be very confident about $GLYC.… https://t.co/b8E66nmn6T January 17th 2021, 2:01am |
 |
@fm23 $GLYC https://t.co/PeMpGYMb7g January 16th 2021, 2:01pm |
 |
@rmacmillan310 $GLYC holding until $4.24 dollars a share https://t.co/4HAc7KkPtG January 16th 2021, 3:01am |
 |
@drndvn34 RT @offshorehunters: $GLYC longer term chart, range starting to tighten up here, on watch https://t.co/qBsz7suhBN January 15th 2021, 9:01pm |
 |
@offshorehunters $GLYC longer term chart, range starting to tighten up here, on watch https://t.co/qBsz7suhBN January 15th 2021, 8:01pm |
 |
@PMDiChristina $GLYC back again, liking this look https://t.co/To4gqyjWUo January 15th 2021, 7:01pm |
|
@rmacmillan310 $GLYC significant price movement on this stock 4.39 % change recently https://t.co/4HAc7KkPtG January 15th 2021, 6:01pm |
 |
@JamieLaceyPR Looking forward to hearing $GLYC CEO Rachel King (#client) and other industry leaders during this podcast #biotech https://t.co/NR2uOCgHds January 15th 2021, 2:01pm |
 |
@CaseyCaseylive $isr received FDA approval last week. $glyc will get it in the coming weeks for their drugs treating AML. Similar p… https://t.co/ocnLvXgzpA January 15th 2021, 1:01am |
 |
@mediasentiment $GLYC new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 970 January 12th 2021, 11:01pm |
 |
@grahm_drake @BuyerHigh $Glyc ? January 12th 2021, 8:01pm |
|
@BlueBioNow $GLYC definitely going to finish under $3.40 -2.07 % change recently https://t.co/XgwQoI5WeD January 11th 2021, 6:01pm |
|
@mediasentiment $GLYC new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 328 January 11th 2021, 11:01am |
|
@mediasentiment $GLYC new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 327 January 11th 2021, 11:01am |
|
@Tickeron $GLYC in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on December 21, 2020. View od… https://t.co/mR0sXhM204 January 11th 2021, 11:01am |
 |
@gcassidy718 $GLYC Looking worse than ever. -2.07 % change recently https://t.co/OpTFVD2XBu January 11th 2021, 10:01am |
|
@BlueBioNow $GLYC Holding this one for the long haul. -2.07 % https://t.co/XgwQoI5WeD January 11th 2021, 12:01am |
 |
@GeorgeB14941177 RT @mesuterturk: Compared to an average industry price book ratio of 4.55, $GLYC is valued rather cheaply. On top of this, it is cheaper th… January 10th 2021, 3:01pm |
 |
@mesuterturk Compared to an average industry price book ratio of 4.55, $GLYC is valued rather cheaply. On top of this, it is che… https://t.co/SiAoyrE5Wo January 10th 2021, 1:01pm |
|
@gcassidy718 $GLYC substantial price changes on this stock -2.07 % https://t.co/OpTFVD2XBu January 10th 2021, 4:01am |
|
@BlueBioNow $GLYC Hoping to exit this position at some point . . . -2.33 % change recently https://t.co/XgwQoI5WeD January 9th 2021, 8:01pm |
 |
@neinto5 $GLYC expecting a FPRX kind of move here. recent good news. still in accumulation. January 9th 2021, 2:01pm |
|
@BlueBioNow $GLYC watching closely ... Over $4.25 this rips 4.32 % change recently https://t.co/XgwQoI5WeD January 9th 2021, 5:01am |
|
@gcassidy718 $GLYC "Everything is impossible until someone does it" 4.19 % change recently https://t.co/OpTFVD2XBu January 8th 2021, 2:01am |
 |
@tradersreport RT @Tickeron: $GLYC's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and oth… January 7th 2021, 9:01pm |
|
@Tickeron $GLYC's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/tWq6N0lrQ7 January 7th 2021, 9:01pm |
 |
@SmallCapsDaily $GLYC APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Le… https://t.co/WVtDk1zaD4 January 7th 2021, 3:01pm |
 |
@MarcJacksonLA $GLYC APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Le… https://t.co/YhQcV8bPLP January 7th 2021, 11:01am |
 |
@Gambiste1 RT @RVH_Investing: $GLYC APL-106 Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia January 7th 2021, 10:01am |
|
@Gambiste1 RT @IOInvestors: $GLYC +4.9% (announced APL-106 has been granted Breakthrough Therapy Designation from the China NMPA Center for Drug Evalu… January 7th 2021, 9:01am |
 |
@Briefingcom $GLYC: GlycoMimetics announced APL-106 has been granted Breakthrough Therapy Designation from the China NMPA Center… https://t.co/dSB5xh2RPF January 7th 2021, 9:01am |
 |
@RVH_Investing $GLYC APL-106 Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia January 7th 2021, 9:01am |
 |
@IOInvestors $GLYC +4.9% (announced APL-106 has been granted Breakthrough Therapy Designation from the China NMPA Center for Dru… https://t.co/NRbotYEuRg January 7th 2021, 9:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Make Better Decisions
Finding and Evaluating Generic and Branded Drug Market Entry Opportunities